menu search

Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference

Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference
CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in a virtual presentation at the SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 10:00 AM ET. […] The post Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conferenc... Read More
Posted: Feb 8 2023, 22:00
Author Name: forextv
Views: 102883

Search within

Pages Search Results: